NDC product
Panixine Disperdose
NDC 10631-574 · Ranbaxy Laboratories Inc.
Key facts
| Product NDC | 10631-574 |
|---|---|
| Proprietary name | Panixine Disperdose |
| Labeler | Ranbaxy Laboratories Inc. |
| Marketing category | ANDA |
| Application number | ANDA065100 |
| Marketing start | May 5, 2004 |
| Marketing end | Apr 25, 2012 |
| Listing certified through | Apr 25, 2012 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: